{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:54:02Z","timestamp":1792112042257,"version":"4.4.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1080\/14756366.2018.1461097","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T04:31:40Z","timestamp":1525062700000},"page":"804-808","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Fluoroenesulphonamides:\n                    <i>N<\/i>\n                    -sulphonylurea isosteres showing nanomolar selective cancer-related transmembrane human carbonic anhydrase inhibition"],"prefix":"10.1080","volume":"33","author":[{"given":"Benoit","family":"M\u00e9tayer","sequence":"first","affiliation":[{"name":",","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Mingot","sequence":"additional","affiliation":[{"name":",","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Jouvin","sequence":"additional","affiliation":[{"name":",","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwilherm","family":"Evano","sequence":"additional","affiliation":[{"name":",","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Thibaudeau","sequence":"additional","affiliation":[{"name":",","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3554"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.422"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.21497"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2014.10.015"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22400"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1039\/c0cc02707c"},{"key":"e_1_3_2_8_1","first-page":"73","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applicationsOrg Biomol Chem","author":"Alterio V","year":"2009","unstructured":"(a) Alterio V, Di Fiore A, D\u2019Ambrosio K, et\u00a0al. Xray crystallography of CA inhibitors and its importance in drug design. In: Supuran CT, Winum JY. eds. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Wiley: Hoboken (NJ); 2009:73\u2013138. (b) Temperini C, Cecchi A, Scozzafava A, Supuran CT, Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited\u2014old leads for new applications? Org Biomol Chem 2008;6:2499\u20132506;"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1039\/c1cc14575d"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr200176r"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2467"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.05.009"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja809683v"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301625s"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3cc40858b"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3ob41538d"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.05.021"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.01.019"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101541x"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.01.036"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00171a013"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.3.331"},{"key":"e_1_3_2_22_1","first-page":"5540","article-title":"A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies","volume":"9","author":"Fourouzesh B","year":"2003","unstructured":"(a) Fourouzesh B, Takimoto CH, Goetz A, et\u00a0al. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies. Clin Cancer Res 2003;9:5540\u20139. (b) Boyd NH, Walker K, Fried J, et\u00a0al. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2017;2:92928.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501314c"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867053363540"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.7b00280"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1039\/c2cc31768k"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo502699y"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)62326-9"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050333c"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201310709"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0223-5234(96)85163-4"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1039\/C3CC47447J"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2014.910202"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2016.1201479"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2011.641015"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2018.1461097","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2018.1461097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:33:43Z","timestamp":1770917623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2018.1461097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1080\/14756366.2018.1461097"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2018.1461097","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}